Patient Care
Physicians increasing HPV vaccine rates for populations with greatest cancer risk
June 14, 2020
Physicians/researchers are dedicated to educating males and childhood cancer survivors on their need for the HPV vaccine. While initial publicity campaigns targeted females, HPV causes cancer in both sexes and disproportionately in survivors.
GRACIAS Texas: Empowering South Texas’ underserved population
June 14, 2020
GRACIAS Texas (Genetic Risk Assessment for Cancer in All South Texas) is dedicated to cancer screening and cancer prevention education for thousands of residents living in the rural communities, towns and cities south of San Antonio.
FDA approves new drug to treat rare blood cancer myelofibrosis
June 14, 2020
Mays Cancer Center director is part of an international research team that developed a new drug to treat myelofibrosis, a rare blood cancer. The U.S. Food and Drug Administration approved the new drug.
Local clinician named 2019 MPN Hero for work on myeloproliferative neoplasms
June 14, 2020
CURE Media Group awarded a 2019 MPN Heroes award to Robyn Scherber, M.D., M.P.H., a nationally recognized clinician and hematologist, for her work in the field of rare blood cancers.
Medical oncologist Dr. Laura Tenner named health policy Fellow
June 14, 2020
The American Society of Clinical Oncology (ASCO) named Medical Oncologist Laura Tenner, M.D., M.P.H., a Health Policy Leadership Development Program Fellow for 2019-2020.
Symposium educates public on the cancer journey
June 9, 2020
More than 500 people attended the inaugural Living Beyond Cancer A – Z symposium on Jan. 12, 2019. The free event offered information on specific types of cancer, support services and coping mechanisms for the cancer journey.
Precision Medicine in Prostate Cancer Symposium educates local residents
June 9, 2020
The Precision Medicine in Prostate Cancer Symposium was a free event in March 2019 open to the public and attended by prostate cancer survivors and community members interested in prostate cancer screening.